Integrated production of human insulin and its C-peptide

Blight, 1994, Protein secretion pathways in Escherichia coli, Curr. Opin. Biotechnol., 5, 468, 10.1016/0958-1669(94)90059-0 Carter, 1990, From molecular mechanism to large-scale processes, 181 Chan, 1981, Biosynthesis and periplasmic segregation of human proinsulin in Escherichia coli, 78, 5401 Cole, 1967, Sulfitolysis, Methods Enzymol., 11, 206, 10.1016/S0076-6879(67)11024-0 Cousens, 1987, High level expression of proinsulin in yeast, Saccharomyces cerevisiae, Gene, 61, 265, 10.1016/0378-1119(87)90190-9 Dalbøge, 1987, A novel enzymatic method for production of authentic hGH from an Escherichia coli produced hGH-precursor, Bio/Technology, 5, 161, 10.1038/nbt0287-161 Datar, 1993, Process economics of animal cell and bacterial fermentations: a case study analysis of tissue plasminogen activator, Bio/Technology, 11, 349, 10.1038/nbt0393-349 deGeus, 1987, Expression of porcine pancreatic phospholipase A2. Generation of active enzyme by sequence-specific cleavage of a hybrid protein from Escherichia coli, Nucl. Acids Res., 15, 3743, 10.1093/nar/15.9.3743 Forsberg, 1992, An evaluation of different enzymatic cleavage methods for recombinant fusion proteins, applied on Des(1–3)insulin-like growth factor I, J. Protein Chem., 11, 201, 10.1007/BF01025226 Frank, 1981, The production of human proinsulin and its transformation to human insulin and C-peptide, 729 Guo, 1984, Synthesis of human insulin gene. Construction of expression vectors for fused proinsulin production in Escherichia coli, Gene, 29, 251, 10.1016/0378-1119(84)90186-0 Hansson, 1994, Single-step recovery of a secreted recombinant protein by expanded bed adsorption, Bio/Technology, 12, 285, 10.1038/nbt0394-285 Jansson, 1996, High level production of uniformly 15N-and 13C-enriched fusion proteins in Escherichia coli, J. Biomol. NMR, 7, 131, 10.1007/BF00203823 Johansson, 1992, The influence of human C-peptide on renal function and glucose utilization in type I (insulin-dependent) diabetic patients, Diabetologia, 35, 121, 10.1007/BF00402543 Johansson, 1993, Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1, J. Clin. Endocrinol. Metab., 77, 976, 10.1210/jc.77.4.976 Johnson, 1983, Human insulin from recombinant DNA technology, Nature, 219, 632 Jonasson, 1996, Single-step trypsin cleavage of a fusion protein to obtain human insulin and its C-peptide, Eur. J. Biochem., 236, 656, 10.1111/j.1432-1033.1996.00656.x Josephson, 1988, Secretion of peptides from E. coli: a production system for the pharmaceutical industry, Trends Biotechnol., 6, 218, 10.1016/0167-7799(88)90077-7 Kang, 1994, Effect of modification of connecting peptide of proinsulin on its export, J. Biotechnol., 36, 45, 10.1016/0168-1656(94)90022-1 Kemmler, 1971, Studies on the conversion of proinsulin to insulin, J. Biol. Chem., 246, 6786, 10.1016/S0021-9258(19)45914-0 Köhler, 1991, Engineering proteins to enhance their partitioning coefficients in aqueous two-phase systems, Bio/Technology, 9, 642, 10.1038/nbt0791-642 Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0 Moks, 1987, Large-scale affinity purification of human insulin-like growth factor I from culture medium of Escherichia coli, Bio/Technology, 5, 379, 10.1038/nbt0487-379 Murby, 1991, Stabilization of recombinant proteins from proteolytic degradation in Escherichia coli using a dual affinity fusion strategy, Biotechnol. Appl. Biochem., 14, 336 Murby, 1994, Production and recovery of recombinant proteins of low solubility, 3, 336 Nilsson, 1987, A synthetic IgG-binding domain based on staphylococcal protein A, Protein Eng., 1, 107, 10.1093/protein/1.2.107 Nygren, 1994, Engineering proteins to facilitate bioprocessing, Trends Biotechnol., 12, 184, 10.1016/0167-7799(94)90080-9 Olsson, 1979, Analysis of rpsD mutations in Escherichia coli, Mol. Gen. Genet., 169, 251, 10.1007/BF00382271 Rudolph, 1995, Successful protein folding on an industrial scale, 283 Samuelsson, 1991, Facilitated in vitro refolding of human recombinant insulin-like growth factor I using a solubilizing fusion partner, Bio/Technology, 9, 363, 10.1038/nbt0491-363 Samuelsson, 1994, Enhanced in vitro refolding of insulin-like growth factor I using a solubilizing fusion partner, Biochemistry, 33, 4207, 10.1021/bi00180a013 Shen, 1984, Multiple joined genes prevent product degradation in Escherichia coli, 81, 4627 Ståhl, 1988, Selection for signal sequence mutations that enhance production of secreted human proinsulin by Escherichia coli, Gene, 71, 147, 10.1016/0378-1119(88)90086-8 Talmadge, 1982, Cellular location affects protein stability in Escherichia coli, 79, 1830 Uhlén, 1992, Fusion proteins in biotechnology, Curr. Opin. Biotechnol., 3, 363, 10.1016/0958-1669(92)90164-E Wang, 1989, Recombinant bovine lactalbumin obtained by limited proteolysis of a fusion protein expressed at high levels in Escherichia coli, J. Biol. Chem., 264, 21116, 10.1016/S0021-9258(19)30054-7 Williams, 1982, Cytoplasmic inclusion bodies in Escherichia coli producing biosynthetic human insulin proteins, Science, 215, 687, 10.1126/science.7036343